申请人:Smithkline Beckman Corporation
公开号:US04452808A1
公开(公告)日:1984-06-05
A series of new chemical compounds which are 4-aminoalkyl-2(3H)-indolones has been demonstrated to be D.sub.2 -agonists useful for treating hypertension. A representative compound of the series is 4-di-n-propylaminoethyl-2(3H)-indolone.
一系列新的化合物被证明是4-氨基烷基-2(3H)-吲哚酮,可用于治疗高血压,其作用机制为D.sub.2-激动剂。该系列的代表化合物是4-二-n-丙基氨乙基-2(3H)-吲哚酮。